Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers

British Journal of Cancer

Volumn 95, Issue 4, 2006, Pages 515-519

  Clarke, C L ^a,c   Sandle, J ^a,d   Jones, A A ^a   Sofronis, A ^a   Patani, N R ^b   Lakhani, S R ^a,c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

BRCA1; BRCA2; Loss of heterozygosity; Normal breast

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ALLELE; ARTICLE; BREAST CELL; CELL CLONE; CONTROLLED STUDY; GENE LOCUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR RECURRENCE; TUMOR VOLUME;

BREAST; BREAST NEOPLASMS; CLONE CELLS; FEMALE; GENE FREQUENCY; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOSS OF HETEROZYGOSITY; MASTECTOMY; MUTATION;

EID: 33747196895     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603298     Document Type: Article

References (31)

1. Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W (1999a) Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 187: 396-402
2. Buerger H, Otterbach F, Simon R, Schafer KL, Poremba C, Diallo R, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W (1999b) Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 189: 521-526
3. Buerger H, Simon R, Schafer KL, Diallo R, Littmann R, Poremba C, van Diest PJ, Dockhorn-Dworniczak B, Bocker W (2000) Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 53: 118-121
4. Cavalli LR, Singh B, Isaacs C, Dickson RB, Haddad BR (2004) Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer. Cancer Genet Cytogenet 149: 38-43
5. Collins N, McManus R, Wooster R, Mangion J, Seal S, Lakhani SR, Ormiston W, Daly PA, Ford D, Easton DF, Stratton MR (1995) Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 10: 1673-1675
6. Cornelis RS, Neuhausen SL, Johansson O, Arason A, Kelsell D, Ponder BA, Tonin P, Hamann U, Lindblom A, Lalle P, Longy M, Olah E, Scherneck S, Bignon YJ, Sobol H, Changelaude J, Larsson C, Spurr N, Borg A, Barkardottir RB, Narod S, Devilee P (1995) High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer 13: 203-210
7. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS (1996) Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274: 2057-2059
8. Ellsworth DL, Ellsworth RE, Love B, Deyarmin B, Lubert SM, Mittal V, Hooke JA, Shriver CD (2004) Outer breast quadrants demonstrate increased levels of genomic instability. Ann Surg Oncol 11: 861-868
9. Farabegoli F, Champeme MH, Bieche I, Santini D, Ceccarelli C, Derenzini M, Lidereau R (2002) Genetic pathways in the evolution of breast ductal carcinoma in situ. J Pathol 196: 280-286
10. Hanby AM, Kelsell DP, Potts HW, Gillett CE, Bishop DT, Spurr NK, Barnes DM (2000) Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer. Int J Cancer 88: 204-208
11. Johnson SM, Shaw JA, Walker RA (2002) Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2. Int J Cancer 98: 205-209
12. Jones C, Damiani S, Wells D, Chaggar R, Lakhani SR, Eusebi V (2001) Molecular cytogenetic comparison of apocrine hyperplasia and apocrine carcinoma of the breast. Am J Pathol 158: 207-214
13. Jones C, Merrett S, Thomas VA, Barker TH, Lakhani SR (2003) Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast. J Pathol 199: 152-156
14. Katsama A, Sourvinos G, Zachos G, Spandidos DA (2000) Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma. Cancer Lett 150: 165-170
15. Lakhani SR, Collins N, Sloane JP, Stratton MR (1995a) Loss of heterozygosity in lobular carcinoma in situ of the breast. Clin Mol Pathol 48: M74-M78
16. Lakhani SR, Collins N, Stratton MR, Sloane JP (1995b) Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 48: 611-615
17. Lakhani SR, Slack DN, Hamoudi RA, Collins N, Stratton MR, Sloane JP (1996) Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest 74: 129-135
18. Lakhani SR, Chaggar R, Davies S, Jones C, Collins N, Odel C, Stratton MR, O'Hare MJ (1999) Genetic alterations in 'normal' luminal and myoepithelial cells of the breast. J Pathol 189: 496-503
19. Larson PS, Schlechter BL, de las Morenas A, Garber JE, Cupples LA, Rosenberg CL (2005) Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues. J Clin Oncol 23: 8613-8619
20. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM (1998) Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 58: 4721-4727
21. Meng ZH, Ben Y, Li Z, Chew K, Ljung BM, Lagios MD, Dairkee SH (2004) Aberrations of breast cancer susceptibility genes occur early in sporadic breast tumors and in acquisition of breast epithelial immortalization. Genes Chromosomes Cancer 41: 214-222
22. Merajver SD, Frank TS, Xu J, Pham TM, Calzone KA, Bennett-Baker P, Chamberlain J, Boyd J, Garber JE, Collins FS, Weber BA (1995) Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Clin Cancer Res 1: 539-544
23. O'Hare MJ (1990) Breast cancer. In Human Cancer in Primary Culture. A Handbook Masters J (ed) pp 271-286. Dordrecht: Kluwer
24. Osorio A, de la Hoya M, Rodriguez-Lopez R, Martinez-Ramirez A, Cazorla A, Granizo JJ, Esteller M, Rivas C, Caldes T, Benitez J (2002) Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer 99: 305-309
25. Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR (2005a) Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29: 734-746
26. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR (2005b) Molecular evolution of breast cancer. J Pathol 205: 248-254
27. Stratton MR, Collins N, Lakhani SR, Sloane JP (1995) Loss of heterozygosity in ductal carcinoma in situ of the breast. J Pathol 175: 195-201
28. Tot T (2005) DCIS, cytokeratins, and the theory of the sick lobe. Virchows Arch 447: 1-8
29. Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ (1997) E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76: 1131-1133
30. Wolman SR, Smith HS, Stampfer M, Hackett AJ (1985) Growth of diploid cells from breast cancers. Cancer Genet Cytogenet 16: 49-64
31. Zhou X, Rao NP, Cole SW, Mok SC, Chen Z, Wong DT (2005) Progress in concurrent analysis of loss of heterozygosity and comparative genomic hybridization utilizing high density single nucleotide polymorphism arrays. Cancer Genet Cytogenet 159: 53-57